affno abstract
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease2014· article· en· Clinical Gastroenterology and Hepatology· Biochemistry, Genetics and Molecular Biology
301
citations
Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.